Neuropsychobiology

Biological Psychiatry. Editor: J. Mendlewicz (Brussels). Original Paper

Trait Characteristic of Impaired Visuomotor Integration during Trail-Making Test B Performance in Schizophrenia

Wölwer W.a · Falkai P.b · Streit M.a · Gaebel W.a

Author affiliations

aDepartment of Psychiatry, Heinrich Heine University Düsseldorf, Düsseldorf, and bDepartment of Psychiatry, University of Homburg, Homburg, Germany

Keywords: Trait markerEye movementsHand movementsPlanningSchizophreniaTrail-making test

Related Articles for ""
Neuropsychobiology 2003;48:59–67
https://doi.org/10.1159/000072878

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Biological Psychiatry. Editor: J. Mendlewicz (Brussels). Original Paper

Published online: September 26, 2003
Issue release date: September 2003

Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 2

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Abstract

Using concurrent recording of eye and hand movements during the performance of the Trail-Making Test B (TMT-B), Wölwer and Gaebel have recently reported impaired visuomotor integration in patients with acute schizophrenia, which mainly accounted for patients’ poor test performance. In order to replicate these exploratory findings in an independent sample of patients and to further investigate their stability during different stages of the illness, the performance process during a computerized TMT-B was assessed in 22 remitted outpatients with schizophrenia, 12 unaffected first-degree relatives and 26 healthy controls. As an estimate of longitudinal stability, a partial sample of 12 patients and 19 controls was reassessed after a period of 3 months. Remitted schizophrenia patients showed exactly the same strategic problems during the performance process of TMT-B as previously found in acute patients. Compared with healthy controls, patients more often sequenced searching (‘planning’) and connecting targets instead of time-sparing parallel execution, and their planning periods contained more and longer planning fixations (i.e. fixations outside the cursor area), which was related to longer performance time. Unaffected relatives mostly scored between patients and healthy controls without statistically significant differences to either group. Thus, the abnormalities in the process of TMT-B performance proved to be reliable and stable trait characteristics in schizophrenia.

© 2003 S. Karger AG, Basel



Related Articles:

References

  1. Heinrichs RW, Zakzanis KK: Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 1998;12:426–445.
    External Resources
  2. Nuechterlein KH, Dawson ME: A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1984;10:300–312.
    External Resources
  3. Nuechterlein KH: Vulnerability models for schizophrenia: State of the art; in Häfner HG, Janzarik W (eds): Search for the Causes of Schizophrenia. Berlin, Springer, 1987, pp 297–316.
  4. Saccuzzo DP, Braff DL: Information-processing abnormalities: Trait- and state-dependent components. Schizophr Bull 1986;12:447–459.
    External Resources
  5. Rund BR, Landro NI, Orbeck AL: Stability in cognitive dysfunctions in schizophrenic patients. Psychiatry Res 1997;69:131–141.
    External Resources
  6. Nuechterlein KH, Dawson ME, Ventura J, Fogelson D, Gitlin M, Mintz J: Testing vulnerability models: Stability of potential vulnerability indictors across clinical state; in Häfner HGW (ed): Search for the Causes of Schizophrenia. Berlin, Springer, 1991, vol 2, pp 177–191.
  7. Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, Yee CM, Mintz J: Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophr Bull 1992;18:387–425.
    External Resources
  8. Rund BR: A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998;24:425–435.
    External Resources
  9. Gold S, Arndt S, Nopoulos P, O’Leary DS, Andreasen NC: Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry 1999;156:1324–1348.
  10. Censits DM, Ragland JD, Gur RC, Gur RE: Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study. Schizophr Res 1997;24:289–298.
    External Resources
  11. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T: Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: A prospective cohort study. Schizophr Bull 2000;26:379–393.
    External Resources
  12. Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho BC, Andreasen NC: Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry 2002;159:1183–1189.
    External Resources
  13. Cornblatt B, Obuchowski M, Roberts S, Pollack S, Erlenmeyer-Kimling L: Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol 1999;11:487–508.
    External Resources
  14. Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Abukmeil SS, Lawrie SM, Miller P, Johnstone EC: Neuropsychological change in young people at high risk for schizophrenia: Results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med 2000;30:1111–1121.
    External Resources
  15. Tranel D, Anderson SW, Benton A: Development of the concept of ‘executive function’ and its relationship to the frontal lobes; in Boller F, Spinnler H, Hendler JA (eds): Handbook of Neuropsychology. Amsterdam, Elsevier, 1994, pp 125–148.
  16. Nopoulos P, Flashman L, Flaum M, Arndt S, Andreasen N: Stability of cognitive functioning early in the course of schizophrenia. Schizophr Res 1994;14:29–37.
    External Resources
  17. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271–276.
  18. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA: Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates. Am J Psychiatry 2000;157:549–559.
    External Resources
  19. Riley EM, McGovern D, Mockler D, Doku VC, O’Ceallaigh S, Fannon DG, Tennakoon L, Santamaria M, Soni W, Morris RG, Sharma T: Neuropsychological functioning in first-episode psychosis – evidence of specific deficits. Schizophr Res 2000;43:47–55.
    External Resources
  20. Albus M, Hubmann W, Ehrenberg C, Forcht U, Mohr F, Sobizack N, Wahlheim C, Hecht S: Neuropsychological impairment in first-episode and chronic schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 1996;246:249–255.
    External Resources
  21. Liddle PF, Morris DL: Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry 1991;158:340–345.
    External Resources
  22. Franke P, Maier W, Hardt J, Hain C: Cognitive functioning and anhedonia in subjects at risk for schizophrenia. Schizophr Res 1993;10:77–84.
    External Resources
  23. Pogue-Geile MF, Garrett AH, Brunke JJ, Hall JK: Neuropsychological impairments are increased in siblings of schizophrenic patients. Schizophr Res 1991;4:390.
    External Resources
  24. Gilvarry CM, Russell A, Hemsley D, Murray RM: Neuropsychological performance and spectrum personality traits in the relatives of patients with schizophrenia and affective psychosis. Psychiatry Res 2001;101:89–100.
    External Resources
  25. Thaker GK, Moran M, Latiti A, Adami H, Tamminga CA, Schulz SC: Pilot studies in schizotypal subjects; in Tamminga CA, Schulz SC (eds): Advances in Neuropsychiatry and Psychopharmacology. New York, Raven, 1991, pp 201–207.
  26. Trestman RL, Keefe RSE, Mitropoulou V, Harvey PD, de Vegvar ML, Lees-Roitman S, Davidson M, Aronson A, Silverman J, Siever LJ: Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Res 1995;59:127–136.
    External Resources
  27. Hoff AL, Riordan H, O’Donnell DW, Morris L, De Lisi LE: Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992;149:898–903.
    External Resources
  28. Rybakowski JK, Borkowska A: Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patients. Schizophr Res 2002;54:105–110.
    External Resources
  29. Lorig TS, Gehring WJ, Hyrn DL: Period analysis of the EEG during performance of the trail making test. Int J Clin Neuropsychol 1986;8:97–99.
  30. Wölwer W, Gaebel W: Impaired trail-making test-B performance in patients with acute schizophrenia is related to inefficient sequencing of planning and acting. J Psychiatr Res 2002;36:407–416.
    External Resources
  31. Wölwer W, Gaebel W: Impaired visuomotor integration in acute schizophrenia. World J Biol Psychiatry 2003;4:126–131.
  32. Vogeley K, Tepest R, Pfeiffer U, Schneider-Axmann T, Maier W, Honer WG, Falkai P; Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: A morphometric MRI study. Am J Psychiatry 2001;158:494–496.
    External Resources
  33. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M, Segman RH, Hanses C, Freymann J, Yakir A, Trixler M, Falkai P, Rietschel M, Maier W, Wildenauer DB: A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6. Mol Psychiatry 2000;5:638–649.
    External Resources
  34. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). Washington, American Psychiatric Association, 1987.
  35. Kliegl R, Olson RK: Automated and interactive analysis of eye fixation data in reading. Behav Res Methods Instrum Comput 1981;13:115–120.
  36. Overall JE, Gorham DR: The brief psychiatric rating scale. Psychol Rep 1962;10:799–812.
  37. Andreasen NC: Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 1982;39:784–788.
    External Resources
  38. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;211:11–19.
  39. Bergen JA, Carter NB, Craig J, MacFarlane D, Smith EF, Beumont PJV: AIMS ratings – repeatability. Br J Psychiatry 1988;152:670–673.
    External Resources
  40. Hutton SB, Puri BK, Duncan LJ, Robbins TW, Barnes TR, Joyce EM: Executive function in first-episode schizophrenia. Psychol Med 1998;28:463–473.
    External Resources
  41. Perecman E: Consciousness and the meta-functions of the frontal lobes: Setting the stage; in Perecman E (ed): The Frontal Lobes Revisited. New York, IRBN Press, 1987, pp 1–10.
  42. Daigneault S, Braun CMJ, Whitaker HA: An empirical test of two opposing theoretical models of prefrontal function. Brain Cogn 1992;19:48–71.
    External Resources
  43. Fuster JM: Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatr Scand Suppl 1999;395:51–57.
    External Resources
  44. Andreasen NC, Paradiso S, O’Leary DS: ‘Cognitive dysmetria’ as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 1998;24:203–218.
    External Resources
  45. Nuechterlein KH, Dawson ME: Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984;10:160–203.
    External Resources
  46. Spring B, Weinstein L, Freeman R, Thompson S: Selective attention in schizophrenia; in Steinhauer SR, Gruzelier JH, Zubin J (eds): Handbook of Schizophrenia. Neuropsychology, Psychophysiology and Information Processing. Amsterdam, Elsevier, 1991, vol 5, pp 371–396.
  47. Venables PH: Cerebral mechanisms, automatic responsiveness and attention to schizophrenia; in Spaulding WD, Cole JK (eds): Theories of Schizophrenia and Psychosis. Lincoln, University of Nebraska Press, 1984, pp 47–91.
  48. Strauss JS: Processes of healing and chronicity in schizophrenia; in Häfner H, Gattaz WF, Janzarik W (eds): Search for the Causes of Schizophrenia. Berlin, Springer, 1987, pp 75–87.
  49. Hemsley DR: What have cognitive deficits to do with schizophrenic symptoms? Br J Psychiatry 1977;130:167–173.
    External Resources
  50. Hemsley DR: A simple (or simplistic?) cognitive model for schizophrenia. Behav Res Ther 1993;31:633–645.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Biological Psychiatry. Editor: J. Mendlewicz (Brussels). Original Paper

Published online: September 26, 2003
Issue release date: September 2003

Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 2

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2003, Vol.48, No. 2

September 2003

Article

Recommend This
TOP